9 research outputs found
Death related to a congenital vascular anomaly of pulmonary hamartoma type: Malpractice or tragic fatality?
In forensic pathology, apparently straightforward cases can often hide rarities that, if not correctly interpreted, can alter the results of the entire investigation, leading to misinterpretations. This occurs when the investigation is conducted to assess medical malpractice. An unexpected death, with no known apparent cause, is often linked to an underlying disease process of unclear etiological origin whose nature can, unfortunately, be properly investigated only post-mortem. This presentation shows a case study, in which it was possible to reconduct the death of a patient to a natural pathology and not to medical treatment. Here, the authors illustrate a case with a hamartoma developed in chronic inflammatory conditions (bronchiectasis) that was difficult to differentiate from lung cancer due to the inability to perform specific instrumental examinations. The hamartoma, usually benign and identifiable by standard instrumental investigations, in this case, led to the patientâs death precisely during the execution of a bronchoscopy. However, in the absence of a certain cause of death, public opinion unanimously attributes a patientâs disease to medical error. Indeed, a routine practice such as bronchoscopy should not cause death and consequently, the doctor must have made a mistake. Fortunately, the autopsy not only demonstrated the origin of the bleeding but also unveiled the reason for this, as rare congenital lung disease. Fate, one might say
A global analysis of Y-chromosomal haplotype diversity for 23 STR loci
In a worldwide collaborative effort, 19,630 Y-chromosomes were sampled from 129 different populations in 51 countries. These chromosomes were typed for 23 short-tandem repeat (STR) loci (DYS19, DYS389I, DYS389II, DYS390, DYS391, DYS392, DYS393, DYS385ab, DYS437, DYS438, DYS439, DYS448, DYS456, DYS458, DYS635, GATAH4, DYS481, DYS533, DYS549, DYS570, DYS576, and DYS643) and using the PowerPlex Y23 System (PPY23, Promega Corporation, Madison, WI). Locus-specific allelic spectra of these markers were determined and a consistently high level of allelic diversity was observed. A considerable number of null, duplicate and off-ladder alleles were revealed. Standard single-locus and haplotype-based parameters were calculated and compared between subsets of Y-STR markers established for forensic casework. The PPY23 marker set provides substantially stronger discriminatory power than other available kits but at the same time reveals the same general patterns of population structure as other marker sets. A strong correlation was observed between the number of Y-STRs included in a marker set and some of the forensic parameters under study. Interestingly a weak but consistent trend toward smaller genetic distances resulting from larger numbers of markers became apparent.Peer reviewe
Allele frequencies of the new European Standard Set (ESS) loci in a population of Apulia (Southern Italy)
Prevalenza Del Diabete Gestazionale Per Epoca Di Gravidanza Negli Anni Compresi Tra Il 1990 Ed Il 1997.
The molecular characterisation of a depurinated trial dna sample can be a model to understand the reliability of the results in forensic genetics
35siThe role of DNA damage in PCR processivity/fidelity is a relevant topic in molecular investigation of aged/forensic samples. In order to reproduce one of the most common lesions occurring in post mortem tissues, a new protocol based in aqueous hydrolysis of the DNA was developed in vitro. Twenty five forensic laboratories were then provided with 3.0 ”g of a trial sample (TS) exhibiting, in mean, the loss of 1 base out of 20, and a molecular weight below 300 bp. Each participating laboratory could freely choose any combination of methods, leading to the quantification and to the definition of the STR profile of the TS, through the documentation of each step of the analytical approaches selected. The results of the TS quantification by qPCR showed significant differences in the amount of DNA recorded by the participating laboratories using different commercial kits. This data shows that only DNA quantification ârelativeâ to the used kit (probe) is possible, being the âabsoluteâ amount of DNA inversely related to the length of the target region (r2=0.891). In addition, our results indicate that the absence of a shared stable and certified reference quantitative standard is also likely involved. STR profiling was carried out selecting five different commercial kits and amplifying the TS for a total number of 212 multiplex PCRs, thus representing an interesting overview of the different analytical protocols used by the participating laboratories. Nine laboratories decided to characterise the TS using a single kit, with a number of amplifications varying from 2 to 12, obtaining only partial STR profiles. Most of the participants determined partial or full profiles using a combination of two or more kits, and a number of amplifications varying from 2 to 27. The performance of each laboratory was described in terms of number of correctly characterised loci, dropped out markers, unreliable genotypes and incorrect results. The incidence of unreliable and incorrect genotypes was found to be higher for participants carrying out a limited number of amplifications, insufficient to define the correct genotypes from damaged DNA samples such as the TS. Finally, from a dataset containing about 4,500 amplicons, the frequency of PCR artefacts (allele drop out, allele drop in and allelic imbalance) was calculated for each kit showing that the new chemistry of the kits is not able to overcome the concern of template-related factors. The results of this collaborative exercise emphasize the advantages of using a standardized degraded DNA sample in the definition of which analytical parameters are critical for the outcome of the STR profiles.reservedmixedFattorini P; Previdere C; Sorçaburu-Cigliero S; Marrubini G; AlĂč M; Barbaro A; Carnevali E; Carracedo A; Casarino L; Consoloni L; Corato S; Domenici R; Fabbri M; Giardina E; Grignani P; Baldassarra SL; Moratti M; Pelotti S; Piccinini A; Pitacco P; Plizza L; Resta N; Ricci U; Robino C; Salvaderi L; Scarnicci F; Schneider PM; Seidita G; Trizzino L; Turchi C; Turrina S; Vatta P; Vecchiotti C; Verzeletti A; De Stefano F.Fattorini, P; Previdere, C; Sorçaburu Cigliero, S; Marrubini, G; AlĂč, M; Barbaro, A; Carnevali, E; Carracedo, A; Casarino, L; Consoloni, L; Corato, S; Domenici, R; Fabbri, M; Giardina, E; Grignani, P; Baldassarra, Sl; Moratti, M; Pelotti, S; Piccinini, A; Pitacco, P; Plizza, L; Resta, N; Ricci, U; Robino, C; Salvaderi, L; Scarnicci, F; Schneider, Pm; Seidita, G; Trizzino, L; Turchi, C; Turrina, S; Vatta, P; Vecchiotti, C; Verzeletti, Andrea; De Stefano, F
The molecular characterisation of depurinated trial DNA sample can be a model to understand the reliability of the results in forensic genetics
The role of DNA damage in PCR processivity/fidelity is a relevant topic in molecular
investigation of aged/forensic samples. In order to reproduce one of the most common
lesions occurring in postmortem tissues, a new protocol based on aqueous hydrolysis
of the DNA was developed in vitro. Twenty-five forensic laboratories were then provided
with 3.0 g of a trial sample (TS) exhibiting, in mean, the loss of 1 base of 20, and a
molecular weight below 300 bp. Each participating laboratory could freely choose any
combination of methods, leading to the quantification and to the definition of the STR
profile of the TS, through the documentation of each step of the analytical approaches
selected. The results of the TS quantification by qPCR showed significant differences in
the amount of DNA recorded by the participating laboratories using different commercial
kits. These data show that only DNA quantification \u201crelative\u201d to the used kit (probe)
is possible, being the \u201cabsolute\u201d amount of DNA inversely related to the length of the
target region (r2 = 0.891). In addition, our results indicate that the absence of a shared
stable and certified reference quantitative standard is also likely involved. STR profiling
was carried out selecting five different commercial kits and amplifying the TS for a total
number of 212 multiplex PCRs, thus representing an interesting overview of the different
analytical protocols used by the participating laboratories. Nine laboratories decided to
characterize the TS using a single kit, with a number of amplifications varying from 2 to
12, obtaining only partial STR profiles. Most of the participants determined partial or full
profiles using a combination of two or more kits, and a number of amplifications varying
from 2 to 27. The performance of each laboratory was described in terms of number
of correctly characterized loci, dropped-out markers, unreliable genotypes, and incorrect
results. The incidence of unreliable and incorrect genotypes was found to be higher for
participants carrying out a limited number of amplifications, insufficient to define the
correct genotypes from damaged DNA samples such as the TS. Finally, from a dataset
containing about 4500 amplicons, the frequency of PCR artifacts (allele dropout, allele
drop-in, and allelic imbalance) was calculated for each kit showing that the new chemistry
of the kits is not able to overcome the concern of template-related factors. The results
of this collaborative exercise emphasize the advantages of using a standardized degraded
DNA sample in the definition of which analytical parameters are critical for the outcome
of the STR profiles
The molecular characterization of a depurinated trial DNA sample can be a model to understand the reliability of the results in forensic genetics.
The role of DNA damage in PCR processivity/fidelity is a relevant topic in molecular investigation of aged/forensic samples. In order to reproduce one of the most common lesions occurring in postmortem tissues, a new protocol based on aqueous hydrolysis of the DNA was developed in vitro. Twenty-five forensic laboratories were then provided with 3.0 ÎŒg of a trial sample (TS) exhibiting, in mean, the loss of 1 base of 20, and a molecular weight below 300 bp. Each participating laboratory could freely choose any combination of methods, leading to the quantification and to the definition of the STR profile of the TS, through the documentation of each step of the analytical approaches selected. The results of the TS quantification by qPCR showed significant differences in the amount of DNA recorded by the participating laboratories using different commercial kits. These data show that only DNA quantification "relative" to the used kit (probe) is possible, being the "absolute" amount of DNA inversely related to the length of the target region (r2 = 0.891). In addition, our results indicate that the absence of a shared stable and certified reference quantitative standard is also likely involved. STR profiling was carried out selecting five different commercial kits and amplifying the TS for a total number of 212 multiplex PCRs, thus representing an interesting overview of the different analytical protocols used by the participating laboratories. Nine laboratories decided to characterize the TS using a single kit, with a number of amplifications varying from 2 to 12, obtaining only partial STR profiles. Most of the participants determined partial or full profiles using a combination of two or more kits, and a number of amplifications varying from 2 to 27. The performance of each laboratory was described in terms of number of correctly characterized loci, dropped-out markers, unreliable genotypes, and incorrect results. The incidence of unreliable and incorrect genotypes was found to be higher for participants carrying out a limited number of amplifications, insufficient to define the correct genotypes from damaged DNA samples such as the TS. Finally, from a dataset containing about 4500 amplicons, the frequency of PCR artifacts (allele dropout, allele drop-in, and allelic imbalance) was calculated for each kit showing that the new chemistry of the kits is not able to overcome the concern of template-related factors. The results of this collaborative exercise emphasize the advantages of using a standardized degraded DNA sample in the definition of which analytical parameters are critical for the outcome of the STR profiles
A global analysis of Y-chromosomal haplotype diversity for 23 STR loci
In a worldwide collaborative effort, 19,630 Y-chromosomes were sampled from 129 different populations in 51 countries. These chromosomes were typed for 23 short-tandem repeat (STR) loci (DYS19, DYS389I, DYS389II, DYS390, DYS391, DYS392, DYS393, DYS385ab, DYS437, DYS438, DYS439, DYS448, DYS456, DYS458, DYS635, GATAH4, DYS481, DYS533, DYS549, DYS570, DYS576, and DYS643) and using the PowerPlex Y23 System (PPY23, Promega Corporation, Madison, WI). Locus-specific allelic spectra of these markers were determined and a consistently high level of allelic diversity was observed. A considerable number of null, duplicate and off-ladder alleles were revealed. Standard single-locus and haplotype-based parameters were calculated and compared between subsets of Y-STR markers established for forensic casework. The PPY23 marker set provides substantially stronger discriminatory power than other available kits but at the same time reveals the same general patterns of population structure as other marker sets. A strong correlation was observed between the number of Y-STRs included in a marker set and some of the forensic parameters under study. Interestingly a weak but consistent trend toward smaller genetic distances resulting from larger numbers of markers became apparent